Cannabinoids, eating behaviour, and energy homeostasis. (Q30357350)

20 June 2017

Cannabinoids, eating behaviour, and energy homeostasis. (English)

1 reference

20 June 2017

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375977%20AND%20SRC:MED&resulttype=core&format=json

Francisco-Javier Bermudez-Silva

12 June 2020

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375977%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Silvana Y Romero-Zerbo

series ordinal

1

1 reference

20 June 2017

Francisco J Bermúdez-Silva

series ordinal

2

1 reference

20 June 2017

language of work or name

1 reference

26 December 2013

1 reference

Drug Testing and Analysis

20 June 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375977%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375977%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375977%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

52-58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375977%20AND%20SRC:MED&resulttype=core&format=json

Adolescent exposure to cannabis as a risk factor for psychiatric disorders

12 June 2020

cites work

1 reference

Cannabinoids in medicine: A review of their therapeutic potential

21 January 2018

1 reference

Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects

21 January 2018

1 reference

The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation

21 January 2018

1 reference

Signal transduction of the CB1 cannabinoid receptor

21 January 2018

1 reference

The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids

21 January 2018

1 reference

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

21 January 2018

1 reference

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂

21 January 2018

1 reference

The emerging role of the endocannabinoid system in endocrine regulation and energy balance

21 January 2018

1 reference

Hyperphagia in pre-fed rats following oral delta9-THC.

21 January 2018

1 reference

Reversal of delta 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine

21 January 2018

1 reference

Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol

21 January 2018

1 reference

Cannabis constituents modulate δ9-tetrahydrocannabinol-induced hyperphagia in rats

21 January 2018

1 reference

A low-Δ9 tetrahydrocannabinol cannabis extract induces hyperphagia in rats

21 January 2018

1 reference

Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice

21 January 2018

1 reference

Cannabinol and cannabidiol exert opposing effects on rat feeding patterns

21 January 2018

1 reference

Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin-1A receptor agonists.

21 January 2018

1 reference

Cannabis sativa and the endogenous cannabinoid system: therapeutic potential for appetite regulation

21 January 2018

1 reference

Central nervous system control of food intake and body weight

21 January 2018

1 reference

The role of the endocannabinoid system in the neuroendocrine regulation of energy balance.

21 January 2018

1 reference

Hypothalamic CB1 cannabinoid receptors regulate energy balance in mice.

21 January 2018

1 reference

Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms

21 January 2018

1 reference

Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin.

21 January 2018

1 reference

The effects of rimonabant on brown adipose tissue in rat: implications for energy expenditure.

21 January 2018

1 reference

CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance

21 January 2018

1 reference

Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB₁ receptor blockade

21 January 2018

1 reference

Leptin-regulated endocannabinoids are involved in maintaining food intake

21 January 2018

1 reference

Rapid glucocorticoid actions in the hypothalamus as a mechanism of homeostatic integration

21 January 2018

1 reference

Expression of cannabinoid CB1 receptors by vagal afferent neurons: kinetics and role in influencing neurochemical phenotype

21 January 2018

1 reference

The tempted brain eats: pleasure and desire circuits in obesity and eating disorders

21 January 2018

1 reference

The cannabinoid antagonist SR 141716A (Rimonabant) reduces the increase of extra-cellular dopamine release in the rat nucleus accumbens induced by a novel high palatable food.

21 January 2018

1 reference

Insulin induces long-term depression of ventral tegmental area dopamine neurons via endocannabinoids

21 January 2018

1 reference

Leptin acts via leptin receptor-expressing lateral hypothalamic neurons to modulate the mesolimbic dopamine system and suppress feeding

21 January 2018

1 reference

Leptin receptor signaling in midbrain dopamine neurons regulates feeding

21 January 2018

1 reference

Cannabinoid1 receptor in the dorsal vagal complex modulates lower oesophageal sphincter relaxation in ferrets

21 January 2018

1 reference

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

21 January 2018

1 reference

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

21 January 2018

1 reference

Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia

21 January 2018

1 reference

The endocannabinoid system links gut microbiota to adipogenesis

21 January 2018

1 reference

Cannabinoid type 1 receptor blockade induces transdifferentiation towards a brown fat phenotype in white adipocytes

21 January 2018

1 reference

Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed wistar rats

21 January 2018

1 reference

Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice

21 January 2018

1 reference

The expression of receptors for endocannabinoids in human and rodent skeletal muscle

21 January 2018

1 reference

Effects of in vitro antagonism of endocannabinoid-1 receptors on the glucose transport system in normal and insulin-resistant rat skeletal muscle

21 January 2018

1 reference

Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice

21 January 2018

1 reference

Regulation of MAP kinase-directed mitogenic and protein kinase B-mediated signaling by cannabinoid receptor type 1 in skeletal muscle cells

21 January 2018

1 reference

Presence of functional cannabinoid receptors in human endocrine pancreas

21 January 2018

1 reference

Cannabinoids inhibit insulin receptor signaling in pancreatic β-cells

21 January 2018

1 reference

The role of the pancreatic endocannabinoid system in glucose metabolism.

21 January 2018

1 reference

Role of the endocannabinoid system in food intake, energy homeostasis and regulation of the endocrine pancreas

21 January 2018

1 reference

Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell.

21 January 2018

1 reference

The CB1 antagonist rimonabant decreases insulin hypersecretion in rat pancreatic islets

21 January 2018

1 reference

Beneficial effect of a chronic treatment with rimonabant on pancreatic function and beta-cell morphology in Zucker Fatty rats.

21 January 2018

1 reference

The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders

21 January 2018

1 reference

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

21 January 2018

1 reference

The endocannabinoid system, eating behavior and energy homeostasis: the end or a new beginning?

21 January 2018

1 reference

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

21 January 2018

1 reference

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

21 January 2018

1 reference

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

21 January 2018

1 reference

The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake

21 January 2018

1 reference

Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats

21 January 2018

1 reference

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

21 January 2018

1 reference

Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance

21 January 2018

1 reference

Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects.

21 January 2018

1 reference

Central functional response to the novel peptide cannabinoid, hemopressin.

21 January 2018

1 reference

Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders

21 January 2018

1 reference

Synthesis and pharmacological activity of a potent inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol

21 January 2018

1 reference

A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol with potential anti-obesity effects

21 January 2018

1 reference

Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats.

21 January 2018

1 reference

Krill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjects

21 January 2018

1 reference

Cannabidiol decreases body weight gain in rats: involvement of CB2 receptors

21 January 2018

1 reference

Overexpression of cannabinoid CB2 receptor in the brain induces hyperglycaemia and a lean phenotype in adult mice.

21 January 2018

1 reference

Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors

21 January 2018

1 reference

7 January 2021

A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.

1 reference

7 January 2021

Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity

1 reference

7 January 2021

Cannabinoid receptor 1 (CB1) antagonism enhances glucose utilisation and activates brown adipose tissue in diet-induced obese mice

1 reference

7 January 2021

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

1 reference

7 January 2021

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study

1 reference

7 January 2021